Medicare Enrolled

Dr. Newah Mofor-Tawo

Physician Assistant · Palm Beach Gardens, FL
Low-engagement
3401 PGA BLVD STE 200, Palm Beach Gardens, FL 33410
5613664100
In practice since 2018 (7 years)
NPI: 1285127134 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mofor-Tawo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mofor-Tawo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mofor-Tawo

Dr. Newah Mofor-Tawo is a physician assistant in Palm Beach Gardens, FL, with 7 years in practice.

Between the years covered by Open Payments, Dr. Mofor-Tawo received a total of $12,802 from 69 pharmaceutical and/or device companies across 660 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mofor-Tawo is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years in practice$ $12,802 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,802
Total received (2021-2024)
Avg $3,200/year across 4 years
Top 1% in FL for physician assistant
69
Companies
660
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,423 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$378 (3.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,978
2023
$3,673
2022
$1,786
2021
$2,365

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,188
Novartis Pharmaceuticals Corporation
$1,123
Daiichi Sankyo Inc.
$729
Sirtex Medical Inc
$729
Merck Sharp & Dohme LLC
$720
Celgene Corporation
$693
Incyte Corporation
$611
Lilly USA, LLC
$563
Seagen Inc.
$470
PFIZER INC.
$444
Janssen Biotech, Inc.
$378
Astellas Pharma US Inc
$371
PUMA BIOTECHNOLOGY, INC.
$309
TerSera Therapeutics LLC
$292
Eisai Inc.
$287
ABBVIE INC.
$260
Takeda Pharmaceuticals U.S.A., Inc.
$256
Ipsen Biopharmaceuticals, Inc
$244
RECORDATI_RARE_DISEASES_INC.
$208
EMD Serono, Inc.
$165
GlaxoSmithKline, LLC.
$164
GENZYME CORPORATION
$161
Deciphera Pharmaceuticals Inc.
$151
SOBI, INC
$140
Pharmacyclics LLC, an AbbVie Company
$124
Stemline Therapeutics Inc.
$116
JAZZ PHARMACEUTICALS INC.
$108
Puma Biotechnology, Inc.
$104
Adaptive Biotechnologies Corporation
$98
Genentech USA, Inc.
$94
SERVIER PHARMACEUTICALS LLC
$85
SANOFI-AVENTIS U.S. LLC
$75
Gilead Sciences, Inc.
$71
Bayer HealthCare Pharmaceuticals Inc.
$71
ARRAY BIOPHARMA INC
$70
Myriad Genetic Laboratories, Inc.
$64
Global Blood Therapeutics, Inc.
$62
MorphoSys, US Inc.
$59
ADC Therapeutics America, Inc.
$58
Regeneron Healthcare Solutions, Inc.
$58
Pharmacyclics LLC, An AbbVie Company
$52
Agios Pharmaceuticals, Inc.
$51
Kyowa Kirin, Inc.
$51
TAIHO ONCOLOGY, INC.
$47
Acrotech Biopharma Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$46
Mirati Therapeutics, Inc.
$43
Immunocore Limited
$39
Amgen Inc.
$39
Acceleron Pharma, Inc.
$36
Pharmacosmos Therapeutics Inc.
$36
Cumberland Pharmaceuticals, Inc.
$34
Alnylam Pharmaceuticals Inc.
$29
Karyopharm Therapeutics Inc.
$25
Biocon Biologics Inc
$24
Dova Pharmaceuticals
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$21
Exelixis Inc.
$19
AbbVie Inc.
$18
PharmaEssentia USA Corporation
$18
ImmunoGen, Inc.
$18
Taiho Oncology, Inc.
$17
Merck Sharp & Dohme Corporation
$16
Foundation Medicine, Inc.
$15
Sobi, Inc
$15
Alexion Pharmaceuticals, Inc.
$13
Clovis Oncology, Inc.
$11
NOVARTIS PHARMACEUTICALS CORPORATION
$4
Top 3 companies account for 23.7% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ADVATE · ALUNBRIG · Aliqopa · BELEODAQ · BESREMI · BOSULIF · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELREXFIO · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Elahere · Enhertu · FOUNDATIONONE · FRUZAQLA · Fabhalta · Fulphila · GIVLAARI · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · ONUREG · OXBRYTA · Onivyde · Orserdu · PADCEV · PANHEMATIN · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Phesgo · Polivy · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · Reblozyl · Rubraca · SANCUSO · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SYLVANT · Somatuline Depot · Stivarga · TABRECTA · TAGRISSO · TEPMETKO · TIBSOVO · TIVDAK · TUKYSA · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · VONVENDI · XALKORI · XPOVIO · Xtandi · YONSA · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ · myChoice CDx · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for physician assistant in FL.

Looking for a physician assistant in Palm Beach Gardens?
Compare physician assistants in the Palm Beach Gardens area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician Assistants within 10 mi
387
Per 100K population
25.7
County median income
$81,115
Nearest hospital
PALM BEACH GARDENS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mofor-Tawo is a physician assistant, and high industry engagement (low-engagement, top 1%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Mofor-Tawo receive payments from pharmaceutical companies?
Yes. Dr. Mofor-Tawo received a total of $12,802 from 69 companies across 660 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Mofor-Tawo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →